Browse by Medical Category
Alzheimer’s disease has traditionally been viewed as a proteinopathy. However, recent evidence highlights circuit disruptions as part of the disease progression. We implement optogenetics to control activity within neuronal circuits and imaging with multiphoton microscopy to monitor circuit dynamics with the aim to dissect the role neural activity plays in onset and development of Alzheimer’s disease.
In an attempt to prevent and/or reverse the disorder, we have partnered with industry leaders to study the effects and mechanisms of action of Alzheimer’s therapeutics, such as anti-Abeta immunotherapy, aducanumab, and the novel multimodal botanical extract DA-9803. We strongly believe that these translational studies are important for getting effective therapies to patients.
Pre-doctoral, post-doctoral opportunities are currently available. Also, technician positions are open. Please contact firstname.lastname@example.org for more information.
Ksenia V. Kastanenka, PhD Massachusetts General Hospital Harvard Medical School 114 Sixteenth St., Rm 2900 Charlestown, MA 02129 USA
Back to Top